Catalyst
Slingshot members are tracking this event:
FDA Issues Guidance Clarifying the Requirements for Developers of Female Sexual Desire Drugs
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 25, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Draft Guidance, Requirements, Female Sexual Desire Drugs, Female Sexual Interest/arousal Disorder, Fsad
